TECNOLOGÍA PARA LA MONITORIZACIÓN Y CONTROL DE LA DIABETES

Volver

Resultados 119 resultados LastUpdate Última actualización 14/12/2018 [16:27:00] pdf PDF




Solicitudes publicadas en los últimos 60 días / Applications published in the last 60 days



previousPage Página2 de 5 nextPage   Mostrar por página


User interfaces for continuous glucose monitoring

NºPublicación: AU2018264074A1 06/12/2018

Solicitante:
DEXCOM INC

Resumen de: AU2018264074A1

The subject matter disclosed herein provides methods for presenting glucose level data. Glucose data for a patient may be received. A current glucose level and a rate of change of the current glucose level may be determined based on the received glucose data. A first interface may be displayed on a screen of a device. The first interface may include a unitary icon. The unitary icon may display the current glucose level and a visualization of the rate of change. Related apparatus, systems, techniques, and articles are also described. <000 Con fn: L 0 WnU 0Ow 0 0 = D 0 0 > _U ZwU C - 0 .C LUJ w C



traducir


 

An apparatus and method

NºPublicación: GB2563112A 05/12/2018

Solicitante:
BIOEPIC LTD [GB]

Resumen de: GB2563112A

There is disclosed an apparatus and a method for calculating a biomarker value. The apparatus includes an analysis module configured to obtain a heartbeat trace of a subject; determine at least one parameter describing the heartbeat trace, and; calculate at least one output biomarker value using at least one Artificial Neural Network ("ANN"). An input of the ANN includes the at least one parameter. An output of the ANN includes the at least one output biomarker value. The ANN may involve a plurality of input 22A, output 23A and hidden neurons 24A. The heartbeat trace may be determined from a video of the subject wherein intensity within a target region of the video is used. The biomarker may be blood glucose level, blood pressure, core or skin temperature, blood gas saturation, histamine levels amongst other examples. The heartbeat trace may be combined from multiple individual heartbeat profiles into a super pulse before input into the ANN.



traducir


 

SYSTEM AND METHOD TO MANAGE DIABETES BASED ON GLUCOSE MEDIAN, GLUCOSE VARIABILITY, AND HYPOGLYCEMIC RISK

NºPublicación: EP3409201A1 05/12/2018

Solicitante:
ABBOTT DIABETES CARE INC [US]

Resumen de: EP3409201A1

A system and method provides a glucose report for determining glycemic risk based on an ambulatory glucose profile of glucose data over a time period, a glucose control assessment based on median and variability of glucose, and indicators of high glucose variability. Time of day periods are shown at which glucose levels can be seen. A median glucose goal and a low glucose line provide coupled with glucose variability provide a view into effects that raising or lowering the median goal would have. Likelihood of low glucose, median glucose compared to goal, and variability of glucose below median provide probabilities based on glucose data. Patterns can be seen and provide guidance for treatment.



traducir


 

BLOOD SUGAR MEASURING APPARATUS

NºPublicación: EP3409202A1 05/12/2018

Solicitante:
PHOENIX SILICON INT CORP [TW]

Resumen de: EP3409202A1

A blood sugar measuring apparatus includes a carrier, a measuring unit installed in the carrier, a calculation unit installed in the carrier and electrically connected to the measuring unit, a display unit installed in the carrier and electrically connected to the calculation unit, and a power unit installed in the carrier and electrically connected to the measuring unit, the calculation unit and the display unit. The blood sugar measuring apparatus is easy to measure the blood sugar without a significant psychological burden and discomfort, but with higher accuracy.



traducir


 

STABILIZED FORMULATIONS CONTAINING ANTI-INTERLEUKIN-6 RECEPTOR (IL-6R) ANTIBODIES

NºPublicación: EP3409269A1 05/12/2018

Solicitante:
REGENERON PHARMA [US]

Resumen de: EP3409269A1

The present invention provides pharmaceutical formulations comprising a human antibody that specifically binds to human interleukin-6 receptor (hIL-6R). The formulations may contain, in addition to an anti-hIL-6R antibody, at least one amino acid, at least one sugar, and/or at least one non-ionic surfactant. The pharmaceutical formulations of the present invention exhibit a substantial degree of antibody stability after storage for several months.



traducir


 

Method of Monitoring Glucose Levels for Weight Loss

NºPublicación: US2018342173A1 29/11/2018

Solicitante:
JORDAN WINSTON [US]

Resumen de: US2018342173A1

The method of monitoring glucose levels begins with the retrieval of at least one daily glucose reading with a user personal computing (PC) device. A daily weight measurement is also retrieved with the user PC device. A daily biometric summary is then relayed from the user PC device to a remote server, wherein the daily biometric summary includes the daily glucose reading and the daily weight measurement. A plurality of iterations is executed in order to compile a user biometric profile, wherein the user biometric profile includes the daily biometric summary for each iteration. The user biometric profile is then compared to the ideal biometric profile with the remote server in order to generate a biometric assessment for the user account. The biometric assessment is outputted with the user PC device for the viewing of the user account.



traducir


 

METHOD AND APPARATUS FOR LIGHT-WEIGHT, NON-INVASIVE, POINT OF CARE DIABETES SCREENING DEVICE

NºPublicación: WO2018217765A1 29/11/2018

Solicitante:
GUPTA RIJUL [US]

Resumen de: WO2018217765A1

A multi-channel measurement device for measuring properties of human tissue, may comprise a microcontroller and first and second source/sensor complexes. The first source/sensor complex may include a first housing having a first measurement portion, a first light sensor coupled to the microcontroller and exposed to the first measurement portion, and a first plurality of light sources coupled to the microcontroller and exposed to the first measurement portion. The second source/sensor complex may include a second housing having a second measurement portion, a second light sensor coupled to the microcontroller and exposed to the second measurement portion, and a second plurality of light sources coupled to the microcontroller and exposed to the second measurement portion. Each combination of an individually activated light source and one of the first and second light sensors provides a distinct measurement channel for measuring the absorption spectra of human blood and tissue.



traducir


 

PORTABLE DEVICE AND METHOD FOR NON-INVASIVE BLOOD GLUCOSE DETECTION

NºPublicación: WO2018214297A1 29/11/2018

Solicitante:
ANYCHECK INFORMATION TECH CO LTD [CN]

Resumen de: WO2018214297A1

Provided are a portable device and method for non-invasive blood glucose detection, the method comprising the following steps: a signal processing circuit (3) controlling an infrared light source (13) to emit near infrared light to radiate at a portion to be detected of a human body; a photoelectric sensor (14) acquiring, from the portion to be detected of the human body, a pulse wave signal, and sending same to the signal processing circuit (3) for signal pre-processing (S31); acquiring the pulse wave signal from the signal processing circuit (3) (S32), and extracting a feature value of the acquired pulse wave signal (S33); using a neural prediction network to detect the feature value of the pulse wave signal, so as to obtain an original detection value of the blood glucose concentration (S34); using a neural classification network to detect the feature value of the pulse wave signal, so as to obtain a detection range of the blood glucose concentration (S35); determining whether the original detection value is within the detection range (S36); and if the original detection value is within the detection range, displaying the original detection value on a display screen (23) as a blood glucose concentration value of the human body (S37). The method can effectively reduce the disturbance on the blood glucose concentration caused by the other components of human body blood, and can improve the accuracy of the blood glucose concentration detection.



traducir


 

GLUCOSE OXIDASE-NANOPARTICLE BIOCONJUGATES FOR CANCER TREATMENT AND USES THEREOF

NºPublicación: WO2018218097A1 29/11/2018

Solicitante:
UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION [US]

Resumen de: WO2018218097A1

Bioconjugates and methods of making bioconjugates are provided, wherein the bioconjugates comprise glucose oxidase and nanoparticles that can kill tumor cells. For example, glucose oxidase-iron oxide bioconjugates can produce reactive oxygen species from blood glucose, causing cell death. The use of superparamagnetic iron oxide nanoparticles can provide magnetic resonance imaging guidance to facilitate imaging- guided drug delivery and combine diagnostics with therapy.



traducir


 

NON-INVASIVE BLOOD GLUCOSE DATA COLLECTION APPARATUS

NºPublicación: WO2018214299A1 29/11/2018

Solicitante:
ANYCHECK INFORMATION TECH CO LTD [CN]

Resumen de: WO2018214299A1

A non-invasive blood glucose data collection apparatus (01), comprising a signal collector (1) and a signal processing circuit (2). The signal collector (1) comprises a support frame (10), an upper detection plate (11), a lower detection plate (12), an infrared light source (13) and a photoelectric sensor (14), wherein a sliding groove (100) is arranged on an upper end of the support frame (10); one end of the upper detection plate (11) is arranged within the sliding groove (100); the lower detection plate (12) is fixed on a lower end of the support frame (10); a hinge mechanism (16) is arranged on an upper surface of the lower detection plate (12), and the hinge mechanism (16) is fixed on the upper surface of the lower detection plate (12); a screw hole (110) is provided in a position, located right above the hinge mechanism (16), of the upper detection plate (11); a screw rod (111) is fixed on an upper end of the hinge mechanism (16); one end of the screw rod (111) is fixed on the upper end of the hinge mechanism (16), and the other end of the screw rod (111) passes through the screw hole (110) and is exposed out of an upper surface of the upper detection plate (11); the infrared light source (13) is embedded in a lower surface of a front end of the upper detection plate (11); and the photoelectric sensor (14) is embedded in an upper surface of a front end of the lower detection plate (12). The non-invasive blood glucose data collection apparatus (01) can efficiently, quick



traducir


 

TUNABLE HYBRID III-V/ IV LASER SENSOR SYSTEM-ON-A-CHIP FOR REAL-TIME MONITORING OF A BLOOD CONSTITUENT CONCENTRATION LEVEL

NºPublicación: WO2018215388A1 29/11/2018

Solicitante:
UAB BROLIS SEMICONDUCTORS [LT]
UNIV GENT [BE]

Resumen de: WO2018215388A1

A spectroscopic laser sensor based on hybrid lll-V/IV system-on-a-chip technology. The laser sensor is configured to either (i) be used with a fiber-optic probe connected to an intravenous/intra-arterial optical catheter for direct invasive blood analyte concentration level measurement or (ii) be used to measure blood analyte concentration level non-invasively through an optical interface attached, e.g., to the skin or fingernail bed of a human. The sensor includes a lll-V gain-chip, e.g., an AIGalnAsSb/GaSb based gain-chip, and a photonic integrated circuit, with laser wavelength filtering, laser wavelength tuning, laser wavelength monitoring, laser signal monitoring and signal output sections realized on a chip by combining IV-based semiconductor substrates and flip-chip AIGalnAsSb/GaSb based photodetectors and embedded electronics for signal processing. Embodiments of the invention may be applied for real-time monitoring of critical blood analyte concentration levels such as lactates, urea, glucose, ammonia, albumin, etc.



traducir


 

NON-INVASIVE BLOOD GLUCOSE DETECTION SYSTEM AND METHOD

NºPublicación: WO2018214298A1 29/11/2018

Solicitante:
ANYCHECK INFORMATION TECH CO LTD [CN]

Resumen de: WO2018214298A1

A non-invasive blood glucose detection system and method. The method comprises the steps of: controlling an infrared light source (13) so that same emits near-infrared light to irradiate a human body part to be detected, and acquiring, by means of a photoelectric sensor (14), a pulse wave signal from the human body part to be detected and under the irradiation of the near-infrared light; pre-processing the pulse wave signal by means of a signal processing circuit (21); extracting a characteristic value of the pulse wave signal; using a predictive neural network to detect the characteristic value of the pulse wave signal so as to obtain an initial detection value of a blood glucose concentration; using a classification neural network to detect the characteristic value of the pulse wave signal so as to obtain a detection interval of the blood glucose concentration; when the initial detection value is within the detection interval, displaying the initial detection value on a display screen (24) as a human body blood glucose concentration value of a person to be detected; and sending, by means of a communication unit (25), the human body blood glucose concentration value and a blood glucose measurement period of the person to be detected to a health management platform (02). The system and method can improve the accuracy of blood glucose concentration detection and enable a person to be detected to accurately understand his/her blood glucose condition.



traducir


 

MANAGEMENT OF THE BLOOD GLUCOSE BALANCE OF A DIABETIC PATIENT

NºPublicación: EP3405895A1 28/11/2018

Solicitante:
VOLUNTIS [FR]

Resumen de: WO2017125682A1

The present invention relates to a medical device (100) for managing the blood glucose balance of a diabetic patient, comprising: a storage module (10) for storing a plurality of blood glucose concentrations measured over a predetermined time period, said measured blood glucose concentrations relating to a content of a blood component representing the blood glucose level of said patient; and a processing circuit (20) that uses a management rule to detect a state of blood glucose imbalance in the patient by comparing said measured blood glucose concentrations with a range of threshold values having an upper blood glucose concentration bound corresponding, for example, to a hyperglycaemic state and a lower blood glucose concentration bound corresponding, for example, to a hypoglycaemic state, said circuit (20) also being configured to emit a warning signal when a state of blood glucose imbalance is detected.



traducir


 

AQUEOUS HUMOR MONITORING DEVICES AND METHODS

NºPublicación: US2018333085A1 22/11/2018

Solicitante:
MICROOPTX INC [US]

Resumen de: US2018333085A1

A method for monitoring glucose concentration in aqueous humor can include inserting an implantable device into an eye and determining glucose concentration as a function of glucose sensed at the implantable device. The method can optionally include optically detecting glucose concentration as a function of polarimetry and/or fluorescence. A system for monitoring glucose concentration can include devices described herein.



traducir


 

Blood Glucose Management

NºPublicación: AU2018256521A1 22/11/2018

Solicitante:
POPS! DIABETES CARE INC

Resumen de: AU2018256521A1

The application discloses a lancet device (100) that includes a base (102) that supports a lancet (104) and a cover (106). The cover can move controllably from an un-depressed position to a depressed position when a predetermined force is applied. The cover can provide access to the lancet in the depressed position. WO 2014/179171 PCT/US2014/035507 Fig. 1 108-' - 120 110 h -106 10o4 d Fig. 2 102 c 104 Fig. 3 100 --- - (120 102 -- 1 04- 8



traducir


 

Continuous glucose monitor communication with multiple display devices

NºPublicación: AU2018260873A1 22/11/2018

Solicitante:
DEXCOM INC

Resumen de: AU2018260873A1

The present disclosure relates to a continuous glucose monitor for wirelessly transmitting data relating to glucose value to a plurality of displays. Systems and methods are disclosed for limiting the number of display devices that can connect to a continuous glucose transmitter. In addition, security, including hashing techniques and a changing application key, can be used to provide secure communications between the continuous glucose transmitter and the displays. Other embodiments relate to a continuous glucose monitor and techniques for authenticating multiple displays, providing secure data transmissions to multiple displays, and coordinating the interaction of commands and data updates between multiple displays. 104b i ii ii i ii ii* 94 DEDICATED DISPLAY 102a 104a DEDICATED DISPL AY TRANSMITTER 100 1% SENSOR103 D -IA -------------------- DEDICATED APPLICATION 102b APPROVED THIRD PARTY APPLICATION 106a 106b



traducir


 

Nighttime Basal Dosing Device

NºPublicación: US2018333531A1 22/11/2018

Solicitante:
BECTON DICKINSON CO [US]

Resumen de: US2018333531A1

A basal hub for attaching to an infusion base is disclosed. The hub includes a fluid reservoir and pressure actuating device. A septum portion of the reservoir is configured to be opened by a flow cannula that is in fluid communication with an infusion cannula of the infusion base, when the basal hub is attached to the infusion base. The pressure actuating device applies pressure to the fluid reservoir, such that when the septum portion of the fluid reservoir is pierced by the by the flow cannula, liquid stored in the fluid reservoir is released from the fluid reservoir into the infusion cannula of the infusion base via the flow cannula. The basal hub is configured to deliver a basal dose of insulin during periods of inactivity, such as during sleep time.



traducir


 

DRUG DELIVERY DEVICE

NºPublicación: US2018333495A1 22/11/2018

Solicitante:
NATIONAL UNIV CORPORATION TOKYO MEDICAL AND DENTAL UNIV [JP]

Resumen de: US2018333495A1

An improved device capable of releasing a drug in response to stimuli such as a glucose concentration is provided. Provided is a drug delivery device, including a porous body such as a hollow fiber having biocompatibility and drug permeability, a stimuli-responsive gel composition filling inside of the porous body, and a drug surrounded by the gel composition inside of the porous body.



traducir


 

SYSTEMS AND METHODS FOR DETERMINING INSULIN THERAPY FOR A PATIENT

NºPublicación: US2018333535A1 22/11/2018

Solicitante:
MONARCH MEDICAL TECH LLC [US]

Resumen de: US2018333535A1

In example methods and systems described, insulin therapy for a patient can be determined. At least one of a short-acting subcutaneous insulin dosage recommendation, a correction subcutaneous insulin dosage recommendation, an intravenous insulin dosage recommendation, a recommended amount of carbohydrates to be administered to the patient, or combinations thereof, can be determined. In addition, information indicating a confirmation of a nutrition intake for the patient, and a long-acting insulin-on-board for the patient can be received, and based on this information, a required long-acting subcutaneous or intravenous insulin dosage for the patient can be determined. The short-acting subcutaneous or intravenous insulin dosage recommendation can be adjusted based, at least in part, on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous or intravenous insulin dosage.



traducir


 

SYSTEMS AND METHODS FOR PROCESSING AND TRANSMITTING SENSOR DATA

NºPublicación: US2018338282A1 22/11/2018

Solicitante:
DEXCOM INC [US]

Resumen de: US2018338282A1

Systems and methods for processing, transmitting and displaying data received from an analyte sensor, such as a glucose sensor, are provided. The data can be displayed on a hand-held display device having a display such as a key fob device including a user interface, such as an LCD and one or more buttons allows a user to view data, and a physical connector, such as USB port.



traducir


 

PREDICTIVE CONTROL MODEL FOR THE ARTIFICIAL PANCREAS USING PAST PREDICTIONS

NºPublicación: EP3402552A1 21/11/2018

Solicitante:
HARVARD COLLEGE [US]
UNIV CALIFORNIA [US]

Resumen de: WO2017123805A1

Presented herein are methods, and devices of adaptively tuning a zone based Model Predictive Control (MPC) controller, using at least one processor, which include determining, residuals based on prediction models storing, in a memory, the determined residuals, calculating a trust index by quantifying uncertainty of the prediction models using the stored residuals and tuning the MPC controller, in real time based on the calculated value of the trust index.



traducir


 

Non-enzymatic glucose-sensing device with nanoporous structure and conditioning of the nanoporous structure

NºPublicación: US10130290B1 20/11/2018

Solicitante:
UXN CO LTD [KR]

Resumen de: US10130290B1

This disclosure relates to a nanoporous composition including a number of clusters of nanoparticles dispersed in a liquid, a nanoporous layer formed of the nanoporous composition, a glucose-oxidation electrode including the nanoporous layer, and a glucose-sensing device and system including the glucose-oxidation electrode. This disclosure also relates to a method of making the nanoporous composition, the nanoporous layer, the glucose-oxidation electrode and the glucose-sensing device and system. Further, this disclosure also relates to devices, systems and methods for continuous glucose monitoring (CGM) and blood glucose monitoring (BGM).



traducir


 

METHOD FOR TREATING AND REVERSING TYPE 2 DIABETES

NºPublicación: US2018325374A1 15/11/2018

Solicitante:
HOCKINGS J MURRAY [US]
HOCKINGS CONSULTING INC DBA HELP YOUR DIABETES [US]

Resumen de: US2018325374A1

Contrary to popular belief, diabetes can be reversed through diet and lifestyle changes. The purpose of the present invention is to provide a method to reduce or eliminate the medication intake of a patient with Type 2 Diabetes. This can also lead to the loss of weight and regaining energy levels. The present invention provides a novel and very effective regimen for treatment of Type 2 diabetes not previously available. It is a further object of the present invention to treat Type 2 diabetes with the combination of a specific meal plan, an exercise regimen and specific supplements for cleansing and overcoming bodily deficiencies.



traducir


 

ANALYTE SENSORS AND METHODS FOR FABRICATING ANALYTE SENSORS

NºPublicación: WO2018208357A1 15/11/2018

Solicitante:
MEDTRONIC MINIMED INC [US]

Resumen de: WO2018208357A1

Analyte sensors and methods for fabricating analyte sensors are provided. In an exemplary embodiment, a planar flexible analyte sensor includes a flexible base layer and a first electrode formed from a layer of sputtered platinum on the base layer. Also, the analyte sensor includes an insulating dielectric layer over the base layer, wherein the insulating dielectric layer leaves a portion of the first electrode exposed. Further, the analyte sensor includes an electrochemical sensing stack over the exposed portion of the first electrode, including a glucose oxidase layer over the layer of sputtered platinum and a glucose limiting membrane over the glucose oxidase layer.



traducir


 

SYSTEM AND METHOD FOR PROVIDING ALERTS OPTIMIZED FOR A USER

Nº publicación: US2018326150A1 15/11/2018

Solicitante:
DEXCOM INC [US]

Resumen de: US2018326150A1

Systems and methods are disclosed that provide smart alerts to users, e.g., alerts to users about diabetic states that are only provided when it makes sense to do so, e.g., when the system can predict or estimate that the user is not already cognitively aware of their current condition, e.g., particularly where the current condition is a diabetic state warranting attention. In this way, the alert or alarm is personalized and made particularly effective for that user. Such systems and methods still alert the user when action is necessary, e.g., a bolus or temporary basal rate change, or provide a response to a missed bolus or a need for correction, but do not alert when action is unnecessary, e.g., if the user is already estimated or predicted to be cognitively aware of the diabetic state warranting attention, or if corrective action was already taken.


traducir



 

previousPage Página2 de 5 nextPage Mostrar por página

Volver